Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Dore

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
AIDS (London, England)|October 1, 1996
Declining incidence and later occurrence of Kaposi's sarcoma among persons with AIDS in Australia: the Australian AIDS cohortG J Dore, Y Li, A E Grulich, et al.
Journal of Viral Hepatitis|May 22, 2015
Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS studyM Alavi, M Micallef, E Fortier, et al.
Journal of Viral Hepatitis|March 4, 2017
Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p studyE B Cunningham, B Hajarizadeh, N A Bretana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2009
Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis CG V Matthews, M Hellard, P Haber, et al.
Journal of Epidemiology and Community Health|March 28, 2015
A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugsT Spelman, M D Morris, G Zang, et al.
Journal of Viral Hepatitis|April 17, 2018
Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infectionM Martinello, S Bhagani, E Gane, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2011
Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis CG V Matthews, S T Pham, M Hellard, et al.
The International Journal on Drug Policy|August 11, 2015
Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife StudyA D Marshall, M Micallef, A Erratt, et al.
Journal of Viral Hepatitis|December 2, 2017
Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international studyM Alavi, N Z Janjua, M Chong, et al.
Genes and Immunity|April 19, 2013
CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infectionV Suppiah, N J Armstrong, K S O'Connor, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
AIDS (London, England)|October 1, 1996
Declining incidence and later occurrence of Kaposi's sarcoma among persons with AIDS in Australia: the Australian AIDS cohortG J Dore, Y Li, A E Grulich, et al.
Journal of Viral Hepatitis|May 22, 2015
Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS studyM Alavi, M Micallef, E Fortier, et al.
Journal of Viral Hepatitis|March 4, 2017
Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p studyE B Cunningham, B Hajarizadeh, N A Bretana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2009
Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis CG V Matthews, M Hellard, P Haber, et al.
Journal of Epidemiology and Community Health|March 28, 2015
A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugsT Spelman, M D Morris, G Zang, et al.
Journal of Viral Hepatitis|April 17, 2018
Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infectionM Martinello, S Bhagani, E Gane, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2011
Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis CG V Matthews, S T Pham, M Hellard, et al.
The International Journal on Drug Policy|August 11, 2015
Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife StudyA D Marshall, M Micallef, A Erratt, et al.
Journal of Viral Hepatitis|December 2, 2017
Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international studyM Alavi, N Z Janjua, M Chong, et al.
Genes and Immunity|April 19, 2013
CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infectionV Suppiah, N J Armstrong, K S O'Connor, et al.
Pageof 7